New radiation rhythm may boost brain cancer survival and save memory
NCT ID NCT07452458
First seen Mar 06, 2026 · Last updated May 25, 2026 · Updated 11 times
Summary
This study tests a new way of giving radiation (TMPRT) for a fast-growing brain cancer called glioblastoma that hasn't responded well to standard chemo. About 398 adults with a specific tumor type (MGMT-unmethylated) will get either standard radiation or TMPRT, both with the chemo drug temozolomide. The goal is to see if TMPRT helps people live longer and protects memory and thinking skills better than standard treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA, IDH-WILDTYPE are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.